Figure 5.
Figure 5. VCAM-1 cleaving activity in bone marrow extracellular fluid. Bone marrow extracellular fluid was harvested from wild-type mice (WT; lanes a-d and i-l), NE × CG-deficient mice (NE × CG; lanes e-h), or DPP-I–deficient mice (lanes m-p) after treatment with saline (–; lanes a, b, e, f, i, j, m, n) or G-CSF (+; lanes c, d, g, h, k, l, o, p). Cleavage of recombinant human VCAM-1 after incubation with bone marrow extracellular fluid was assessed as described in “Materials and methods.” Molecular size markers are indicated at left in kDa.

VCAM-1 cleaving activity in bone marrow extracellular fluid. Bone marrow extracellular fluid was harvested from wild-type mice (WT; lanes a-d and i-l), NE × CG-deficient mice (NE × CG; lanes e-h), or DPP-I–deficient mice (lanes m-p) after treatment with saline (–; lanes a, b, e, f, i, j, m, n) or G-CSF (+; lanes c, d, g, h, k, l, o, p). Cleavage of recombinant human VCAM-1 after incubation with bone marrow extracellular fluid was assessed as described in “Materials and methods.” Molecular size markers are indicated at left in kDa.

Close Modal

or Create an Account

Close Modal
Close Modal